[ACCESSWIRE]
NEW YORK, NY / ACCESSWIRE / April 22, 2016 / The OTC Expert is issuing a report on four stocks that are trading with heavier than usual volume. EBIO, EXXI, SUNE and ATRS are on high volume watch. Continue reading to find out why these stocks are getting so much interest today. - If you want reports on the day's hottest stocks (NYSE/Nasdaq/OTC) subscribe to our newsletter at otc-expert.com.
Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) Is a clinical-stage biopharmaceutical company, engages in the discovery and development of protein therapeutics to treat eye diseases primarily in the United States.
Shares of EBIO are trading higher today by over 10%. The stock appears to be continuing its run after after announcing their strategic update and fourth quarter financial results.
The last several trading days have been great for EBIO and there is no indication that it could be slowing down heading into next week as volume continues to flow into the stock.
Subscribe Free To Receive Alerts Like These Sent To Your Inbox Get Your Free Membership Now.
Energy XXI Ltd. (NASDAQ: EXXI) The company provides acquisition, exploration, development, and operation of oil and natural gas properties in Louisiana, Texas, and the Gulf of Mexico.
When we last tracked EXXI, last Thursday, it had filed for bankruptcy, becoming yet another heavily indebted oil-and-gas company to collapse amid volatile fuel prices.
However, it was trading higher by over 25%, bouncing off its lows. Today, the stock is trading lower by 5%, suggesting that the bounce play may have come to an end.
Like What You See? Get These Alerts and Many More on NASDAQ Companies before They Rally, Find Out More Here.
SunEdison, Inc. (NYSE: SUNE) Is a renewable energy development company, develops, finances, installs, owns, and operates renewable power plants to residential, commercial, government, and utility customers.
For those of you concerned, SUNE is now trading under the ticker SUNEQ as they continue to try to fix their financial issues.
Shares of SUNEQ are heavily trading off massive volume.
Get the Information You Need To Stay Informed and Up To Date On The Hottest NASDAQ Plays Get Them Here.
Antares Pharma Inc. (NASDAQ: ATRS) Is a specialty pharmaceutical company, focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies worldwide.
Shares of ATRS are trading higher today by 5%. The stock has been trading higher recently and is showing strength after hitting its 52 week low just one month ago.
The influx in volume has helped sustain the stock early in its turnaround, however, with dwindling volume coming now, the stock is showing gains without massive buys.
We will continue to follow ATRS as it continues to make moves above its 50 day moving average.
NASDAQ Stock Alerts: Check Them Out Here To Receive Our Winning NASDAQ & NYSE Stock Alerts For Free.
About otc-expert.com
The OTC Expert is a newsletter alert service that focuses on companies on the NASDAQ & NYSE. We only highlight quality companies with big news on high volume days. This commitment provides our subscribers with only the best recommendations of companies for short and long-term investments.
To receive free text message alerts on your phone, compose a new text message to the number 95577 with the word "OTCLEADER".
Disclosure: The information, opinions and analysis contained in this report are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We do not accept any responsibility or liability for any losses, damages or costs arising from an investor's or other person's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities, nor a recommendation of any security. Past gains are not representative of future gains. The OTC Expert has not been compensated nor does it expect to receive any compensation for distribution of its opinions and publicly available information regarding the companies reported in this investment opinion article at this time. The opinions contained herein contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. When used herein, the words "anticipate," "intend," "estimate," "believe," "expect," "plans," "should," "potential," "forecast," and variations of such words and similar expressions are intended to identify forward-looking statements. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A company's actual results could differ materially from those described in any forward-looking statements contained herein. The OTC Expert is not a licensed broker, broker dealer, market maker, investment advisor, analyst or underwriter. We recommend that you use the information found herein as an initial starting point for conducting your own research in order to determine your own personal opinion of the companies discussed herein before deciding whether or not to invest. You should seek such investment, tax, financial, accounting or legal advice appropriate for your particular circumstances. Information about many publicly traded companies and other investor resources can be found at www.sec.gov. Investing in securities is speculative and carries risk. Please visit otc-expert.com/disclaimer website for a more detailed discussion of risks and disclosures.
Contact:
Justin Skibinski
The OTC Expert
info@otc-expert.com
SOURCE: The OTC Expert